vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1122Research ArticleОБМЕН ОПЫТОМEXCHANGE OF EXPERIENCEАДАЛИМУМАБ: НОВЫЕ ВОЗМОЖНОСТИ ЛЕЧЕНИЯ РЕВМАТИЧЕСКИХ БОЛЕЗНЕЙADALIMUMAB: NEW OPPORTUNITIES OF RHEUMATOID ARTHRITIS TREATMENTАлексееваЕ.И.AlexeevaE.I.ЛисицинА.О.LisitsinA.O.КарагулянН.А.KaragulyanN.A.ЛомакинаО.Л.LomakinaO.L.ВалиеваС.И.ValievaS.I.БзароваТ.М.BzarovaT.M.ДенисоваР.В.DenisovaR.V.ГудковаЕ.Ю.GudkovaE.Yu.ЧомахидзеА.М.ChomakhidzeA.M.ИсаеваК.Б.IsaevaK.B.Научный центр здоровья детей РАМН, МоскваРоссияScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowRussian Federation20092309201583Вопросы современной педиатрии8894Copyright © Алексеева Е., Лисицин А., Карагулян Н., Ломакина О., Валиева С., Бзарова Т., Денисова Р., Гудкова Е., Чомахидзе А., Исаева К., 20092009Алексеева Е., Лисицин А., Карагулян Н., Ломакина О., Валиева С., Бзарова Т., Денисова Р., Гудкова Е., Чомахидзе А., Исаева К.Alexeeva E., Lisitsin A., Karagulyan N., Lomakina O., Valieva S., Bzarova T., Denisova R., Gudkova E., Chomakhidze A., Isaeva K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1122ReferencesTextbook of paediatric rheumatology, 2nd end. Cassidy J., Petty R. (eds.). New York: Churchill Livigstone. 2002.Textbook of paediatric rheumatology, 2nd end. Cassidy J., Petty R. (eds.). New York: Churchill Livigstone. 2002.Алексеева Е.И. Ревматические болезни и их влияние на качество жизни детей и их семей. Качество жизни. Медицина. 2008; 1: 14–17.Алексеева Е.И. Ревматические болезни и их влияние на качество жизни детей и их семей. Качество жизни. Медицина. 2008; 1: 14–17.Horneff G., Augustin S. Medical treatment of juvenile idiopathic arthritis. Med. Monatsschr. Pharm. 2008; 31: 326–336.Horneff G., Augustin S. Medical treatment of juvenile idiopathic arthritis. Med. Monatsschr. Pharm. 2008; 31: 326–336.Ravelli A., Martini A. Juvenile idiopathic arthritis. Lancet. 2007; 369 (9563): 767–878.Ravelli A., Martini A. Juvenile idiopathic arthritis. Lancet. 2007; 369 (9563): 767–878.Hashkes P.J., Laxer R.M. Medical treatment of juvenile idiopathic arthritis. JAMA. 2005; 294 (13): 1671–1684.Hashkes P.J., Laxer R.M. Medical treatment of juvenile idiopathic arthritis. JAMA. 2005; 294 (13): 1671–1684.Schett G. Review: Immune cells and mediators of inflammatory arthritis. Autoimmunity. 2008; 41 (3): 224–229.Schett G. Review: Immune cells and mediators of inflammatory arthritis. Autoimmunity. 2008; 41 (3): 224–229.Bradley J.R. TNF mediated inflammatory disease. J. Pathol. 2008; 214 (2): 149–160.Bradley J.R. TNF mediated inflammatory disease. J. Pathol. 2008; 214 (2): 149–160.Theodossiadis P.G., Markomichelakis N.N., Sfikakis P.P. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina. 2007; 27 (4): 399–413.Theodossiadis P.G., Markomichelakis N.N., Sfikakis P.P. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina. 2007; 27 (4): 399–413.Ackermann C., Kavanaugh A. Tumor necrosis factor as a therapeutic target of rheumatologic disease. Expert Opin. Ther. Targets. 2007; 11 (11): 1369–1384Ackermann C., Kavanaugh A. Tumor necrosis factor as a therapeutic target of rheumatologic disease. Expert Opin. Ther. Targets. 2007; 11 (11): 1369–1384Rubbert-Roth A., Finckh A. Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review. Arthritis. Res. Ther. 2009; 11 (Suppl. 1): 1.Rubbert-Roth A., Finckh A. Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review. Arthritis. Res. Ther. 2009; 11 (Suppl. 1): 1.Weinblatt M.E., Keystone E.C., Furst D.E. et al. Long term safety, efficacy and remission with adalimumab and methotrexate combination therapy in rheumatoid arthritis 7 year analysis. 9th Annual EULAR 2008 meeting. Paris (Abstract AB03043).Weinblatt M.E., Keystone E.C., Furst D.E. et al. Long term safety, efficacy and remission with adalimumab and methotrexate combination therapy in rheumatoid arthritis 7 year analysis. 9th Annual EULAR 2008 meeting. Paris (Abstract AB03043).Weinblatt M.E., Keystone E.C., Furst D.E. et al. Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate the ARMADA trial. Arthritis Rheum. 2003; 48 (1): 35–45.Weinblatt M.E., Keystone E.C., Furst D.E. et al. Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate the ARMADA trial. Arthritis Rheum. 2003; 48 (1): 35–45.Mease P.J., Gladman D.D., Ritchhn C.T. et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double blind, randomized, placebo controlled trial. Arthritis Rheum. 2005; 52 (10): 3279–3289.Mease P.J., Gladman D.D., Ritchhn C.T. et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double blind, randomized, placebo controlled trial. Arthritis Rheum. 2005; 52 (10): 3279–3289.Daniel J. L., Nicola R., Steven G. et al. Preliminary data from the study of adalimumab in children with juvenile idiopathic arthritis (JIA). Pediatric American College of Rheumatology 2004 (Abstract 1096).Daniel J. L., Nicola R., Steven G. et al. Preliminary data from the study of adalimumab in children with juvenile idiopathic arthritis (JIA). Pediatric American College of Rheumatology 2004 (Abstract 1096).Ruperto N., Lovell D.J., Goodman S. et al. Long term efficacy and safety of adalimumab in children with juvenile rheumatoid arthritis (JRA): data over two years of treatment in a phase III study. 8th Annual European League Against Rheumatism (EULAR 2007), 2007. Barcelona, Spain. Abstract THU0195.Ruperto N., Lovell D.J., Goodman S. et al. Long term efficacy and safety of adalimumab in children with juvenile rheumatoid arthritis (JRA): data over two years of treatment in a phase III study. 8th Annual European League Against Rheumatism (EULAR 2007), 2007. Barcelona, Spain. Abstract THU0195.Tynjälä P., Kotaniemi K., Lindahl P. et al. Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. Rheumatology. 2008; 47 (3): 339–344.Tynjälä P., Kotaniemi K., Lindahl P. et al. Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. Rheumatology. 2008; 47 (3): 339–344.Biester S., Deuter C., Michels H., et al. Adalimumab in the therapy of uveitis in childhood. Br. J. Ophthalmol. 2007; 91 (3): 319–324.Biester S., Deuter C., Michels H., et al. Adalimumab in the therapy of uveitis in childhood. Br. J. Ophthalmol. 2007; 91 (3): 319–324.Алексеева Е.И., Валиева С.И., Бзарова Т.М. и др. Опыт применения адалимумаба у больного юношеским анкилозирующим спондилитом с поражением глаз. Вопросы современной педиатрии. 2009; 8 (1): 135–141.Алексеева Е.И., Валиева С.И., Бзарова Т.М. и др. Опыт применения адалимумаба у больного юношеским анкилозирующим спондилитом с поражением глаз. Вопросы современной педиатрии. 2009; 8 (1): 135–141.Лисицин А.О., Алексеева Е.И., Бзарова Т.М. и др. Опыт применения адалимумаба у больной юношеским полиартритом с поражением глаз. Вопросы современной педиатрии. 2008; 7 (5): 115–120.Лисицин А.О., Алексеева Е.И., Бзарова Т.М. и др. Опыт применения адалимумаба у больной юношеским полиартритом с поражением глаз. Вопросы современной педиатрии. 2008; 7 (5): 115–120.Wallace C.A., Ruperto N., Giannini E. et al. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J. Rheumatol. 2004; 31 (11): 2290-2294.Wallace C.A., Ruperto N., Giannini E. et al. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J. Rheumatol. 2004; 31 (11): 2290-2294.Hogan M.J., Kimura S.J., Thygeson P. Signs and symptoms of uveitis. Anterior uveitis. Am. J. Ophthalmol. 1959; 47 (5): 155–170.Hogan M.J., Kimura S.J., Thygeson P. Signs and symptoms of uveitis. Anterior uveitis. Am. J. Ophthalmol. 1959; 47 (5): 155–170.
The authors declare that there are no conflicts of interest present.